Section Arrow
BAX.NYSE
- Baxter International
Quotes are at least 15-min delayed:2025/12/31 11:22 EST
Regular Hours
Last
 19.305
+0.005 (+0.03%)
Day High 
19.35 
Prev. Close
19.3 
1-M High
19.82 
Volume 
1.03M 
Bid
19.3
Ask
19.31
Day Low
19.04 
Open
19.04 
1-M Low
17.92 
Market Cap 
9.92B 
Currency 美元 
P/E 140.32 
%Yield 2.69 
10-SMA 19.13 
20-SMA 18.91 
50-SMA 19.28 
52-W High 37.74 
52-W Low 17.4 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
-0.67/2.22
Enterprise Value
20.54B
Balance Sheet
Book Value Per Share
14.09
Cash Flow
Cash Flow Yield
0.08
Income Statement
Total Revenue
14.81B
Operating Revenue Per Share
29.72
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
EKSOEkso Bionics Holdings Inc9.11-1.47-13.89%-- 
AVTRAvantor11.485+0.015+0.13%11.55PE
MLSSMilestone Scientific0.2839+0.0103+3.76%-- 
BAXBaxter International19.305+0.005+0.03%140.32PE
FEMYFemasys0.5779+0.0049+0.86%-- 
Industry overview quotes are at least 15 minutes delayed
Business Description
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.